Why the Russell 2000 has a real chance to beat the S&P 500 — finally

The Russell 2000 is positioned for a potential reversal after eight years of underperformance, currently trading at its most inexpensive valuation relative to the S&P 500 since 2008. While valuation alone has not been a catalyst, a confluence of factors could drive a shift: rising interest rates are making private capital less abundant, potentially increasing the quality of IPOs; small-cap earnings fundamentals are improving relative to large-caps; and a clearer market regime could enable longer-term investment views. Despite continued narrow market leadership from large-cap tech, these emerging conditions suggest a compelling backdrop for small-cap outperformance, particularly within cyclical sectors like financials, industrials, and materials.

Analysis

After eight consecutive years of underperformance, the Russell 2000 index is trading at its most inexpensive valuation relative to the S&P 500 since 2008, presenting a valuation gap of over one standard deviation. While this discount has existed for the past three years without triggering a mean reversion, several potential catalysts are emerging that could shift investor preference. A key headwind, the historically high percentage of negative-earning companies in the index, may recede as higher interest rates make private capital less abundant. This is fueling a revival in the IPO market, with 95 deals raising $12.9 billion in 2025 so far, compared to 73 deals in all of 2024, which could improve the overall quality of the public small-cap universe. Concurrently, small-cap earnings have begun to show relative improvement against large-caps for the first time since 2022. The primary risk to this thesis is the continued dominance of large-cap technology stocks; as long as AI-related investments post significant returns, capital may remain concentrated. Opportunities within the small-cap space appear most compelling in cyclical sectors like financials, industrials, and materials, where many firms generate significant free cash flow despite valuation discounts. Conversely, small-cap healthcare and consumer discretionary sectors are viewed as less attractive due to heightened operational hurdles and binary risks.

Key Decisions for Investors

• Given the historic valuation discount and emerging fundamental catalysts, investors should consider initiating or increasing strategic allocations to U.S. small-cap equities for potential long-term outperformance.
• Focus small-cap exposure on cyclical sectors such as financials, industrials, and materials, prioritizing companies that are trading at a discount despite generating significant free cash flow.
• Exercise caution with small-cap healthcare and consumer discretionary stocks, as these sectors face greater operational headwinds and are subject to indiscriminate selling on negative news.
• Monitor the health of the IPO market and the relative earnings performance of small-caps versus large-caps as key indicators confirming a sustained shift in market leadership.